Ro 13-9904: Affinity for penicillin binding proteins and effect on cell wall synthesis.
- 1 January 1981
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 34 (5) , 590-595
- https://doi.org/10.7164/antibiotics.34.590
Abstract
Studies on the binding of Ro 13-9904, a new broad-spectrum cephalosporin, showed that it had higher affinities for PBP [penicillin binding proteins] 1b, 2 and 3 of Escherichia coli (3 > 1b > 2) than cefazolin, cephaloridine, cephalothin or cephalexin. With Haemophilus influenzae, Ro 13-9904 showed highest affinities for PBP 4 and 5 followed by PBP-2. It inhibited total cell wall synthesis at lower concentrations than the other .beta.-lactam antibiotics tested.This publication has 6 references indexed in Scilit:
- In vitro evaluation of Ro 13-9904Antimicrobial Agents and Chemotherapy, 1980
- In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporinsAntimicrobial Agents and Chemotherapy, 1980
- Peptidoglycan Transpeptidase Inhibition in Pseudomonas aeruginosa and Escherichia coli by Penicillins and CephalosporinsAntimicrobial Agents and Chemotherapy, 1979
- SCE-963, a New Potent Cephalosporin with High Affinity for Penicillin-Binding Proteins 1 and 3 of Escherichia coliAntimicrobial Agents and Chemotherapy, 1979
- Thermosensitive mutation in Escherichia coli simultaneously causing defects in penicillin-binding protein-1Bs and in enzyme activity for peptidoglycan synthesis in vitro.Proceedings of the National Academy of Sciences, 1977
- Properties of the Penicillin‐Binding Proteins of Escherichia coli K12European Journal of Biochemistry, 1977